市場調查報告書
商品編碼
1383423
到 2030 年色譜設備市場預測:按類型、配件/消耗品、最終用戶和地區進行全球分析Chromatography Instruments Market Forecasts to 2030 - Global Analysis By Type, By Accessory & Consumable, End User and By Geography |
根據Stratistics MRC的數據,2023年全球色譜設備市場規模為105.6億美元,預計到2030年將達到170.7億美元,預測期內年複合成長率為7.1%。
色譜設備是一種用於分離和鑑定混合物中組分的分析工具。它的工作原理是差速傳輸,其中樣品化合物以不同的速度通過固定相,從而實現分離和分析。這些儀器對於化學、製藥、環境科學和生物化學等各個領域的複雜混合物的表徵和定量至關重要。
根據《世界製藥科學雜誌》報道,全球 78% 以上的化學分析是在色譜儀器上進行的。
色譜法已得到廣泛認可,在藥物研究、環境分析以及食品和飲料行業中發揮著至關重要的作用。色譜法以高精度和高靈敏度分離和分析複雜混合物的能力現在至關重要。隨著各行業不斷尋求產品品質、安全性和法規遵從性的改進,色譜儀器在藥物開發、品管和環境監測等應用中的需求量很大,並作為各個領域的重要分析工具進行銷售。支持成長
色譜設備的高成本是色譜設備市場的主要抑制因素。這些設備技術先進,需要精密工程,導致製造成本高。因此,許多實驗室,特別是在資源有限的環境中,面臨預算限制,這可能會阻止他們投資或升級色譜設備。此外,消耗品、維護和操作所需的專業知識等成本也會增加總成本。
對石化產品日益成長的需求增加了對精確、高效的分析工具的需求,以評估產品品質、純度以及對環境法規的遵守情況。氣相層析管技術的進步,包括高溫穩定性、增強的分離能力和改進的耐用性,使得複雜碳氫化合物混合物的分析更加準確和快速。這支持了石化產業對產品最佳化、成本效率和合規性的追求,從而推動了對色譜設備的需求。
儘管色譜法是一種被廣泛接受且有效的分離技術,但質譜法和核磁共振波譜法等替代技術也越來越受到重視,特別是對於複雜樣品的分析。這些替代方案提供不同的功能,並且對於特定應用具有競爭。隨著技術的發展,色譜法面臨日益激烈的競爭的風險,迫使該行業進行創新和適應。
COVID-19大流行對市場產生了中等影響。全球危機擾亂了供應鏈並推遲了色譜設備和消耗品的生產和分銷。它也導致非必要的研究和工業流程暫時放緩,影響了需求。然而,這場大流行凸顯了色譜在醫療保健、診斷和藥物研究中的重要性,導致對測試和藥物開發的需求增加。總體而言,雖然最初的破壞很困難,但這場大流行最終凸顯了色譜設備在應對公共衛生和科學挑戰方面的重要作用。
液相層析系統部分預計將佔據市場上最大的市場佔有率。這項預測主要歸因於液相層析的多功能性、高解析度以及對多種行業的適用性,包括製藥、生物技術、環境分析以及食品和飲料。液相層析可以精確分離和定量化合物,這對於藥物開發、品管和研究至關重要。此外,高效液相層析(HPLC)和超高效液相層析(UHPLC)等液相層析技術的進步進一步增強了其市場主導地位。
生命科學產業有望在市場中實現顯著成長。這種成長的關鍵促進因素是色譜在製藥、生物技術和臨床研究中的使用不斷增加。色譜在藥物開發、品管和生物分子分析中發揮重要作用,特別是在生物製藥和個人化醫療日益成長的需求中。此外,基因組學、蛋白質組學和代謝組學研究對精密分析工具的需求進一步推動了生命科學中色譜設備的採用。
北美擁有許多大型製藥企業、研究機構和臨床實驗室,廣泛使用色譜法進行藥物研發、品管和生物分子分析,使其成為預測期內最大的市場,預計將佔據很大佔有率。此外,醫療保健和生命科學領域嚴格的法規要求正在推動對精密分析設備的需求。此外,對研發的持續關注和完善的醫療基礎設施正在支持該地區的成長。
亞太地區預計將出現顯著的市場成長。該地區的製藥和生技產業快速成長,研發投入不斷增加。此外,新興國家工業化和都市化的不斷發展進一步推動了對環境監測和分析的需求,增加了市場未來性。隨著亞太地區不斷發展成為科學和工業發展中心,色譜設備的採用預計將大幅增加。
According to Stratistics MRC, the Global Chromatography Instruments Market is accounted for $10.56 billion in 2023 and is expected to reach $17.07 billion by 2030 growing at a CAGR of 7.1% during the forecast period. Chromatography instruments are analytical tools used for separating and identifying components within a mixture. They operate on the principle of differential migration, where sample compounds move at different rates through a stationary phase, allowing for separation and analysis. These instruments are essential in various fields, including chemistry, pharmaceuticals, environmental science, and biochemistry, to characterize and quantify complex mixtures.
According to the World Journal of Pharmaceutical Sciences, over 78% of chemical analysis is done by chromatography instruments globally.
Chromatography has gained widespread recognition for its pivotal role in pharmaceutical research, environmental analysis, and the food and beverage industry. Its ability to separate and analyze complex mixtures with high precision and sensitivity has become indispensable. As industries continuously seek to improve product quality, safety, and regulatory compliance, chromatography instruments are in high demand for applications like drug development, quality control, and environmental monitoring, fueling the market's growth as a critical analytical tool for various sectors.
The high cost of chromatography equipment serves as a significant restraint in the chromatography instrument market. These instruments are technologically advanced and require precision engineering, which results in substantial manufacturing expenses. As a result, many laboratories, especially in resource-constrained settings, may face budget limitations that hinder their ability to invest in or upgrade chromatography equipment. Additionally, the cost of consumables, maintenance, and expertise required for operation adds to the overall expenses.
With the increasing demand for petrochemical products, there's a growing need for precise and efficient analytical tools to assess product quality, purity, and compliance with environmental regulations. Advances in GC column technologies, including high-temperature stability, enhanced separation capabilities, and improved durability, enable more accurate and rapid analysis of complex hydrocarbon mixtures. This, in turn, supports the petrochemical industry's pursuit of product optimization, cost-efficiency, and compliance, driving the demand for chromatography instruments.
While chromatography is a widely accepted and effective separation technique, alternative methods, such as mass spectrometry and NMR spectroscopy, are gaining prominence, especially in the analysis of complex samples. These alternatives offer different capabilities and can compete in specific applications. As technology evolves, there is a risk of chromatography facing increased competition, compelling the industry to innovate and adapt.
The COVID-19 pandemic had a moderate impact on the market. The global crisis disrupted supply chains, leading to delays in the production and distribution of chromatography equipment and consumables. It also caused a temporary slowdown in non-essential research and industrial processes, affecting demand. However, the pandemic underscored the critical importance of chromatography in healthcare, diagnostics, and pharmaceutical research, leading to increased demand for testing and drug development. Overall, while the initial disruptions were challenging, the pandemic ultimately highlighted the indispensable role of chromatography instruments in addressing public health and scientific challenges.
The liquid chromatography systems segment is expected to capture the largest market share in the market. This projection is primarily due to the versatility, high resolution, and broad applicability of liquid chromatography in a wide range of industries, including pharmaceuticals, biotechnology, environmental analysis, and food and beverage. Liquid chromatography offers precise separation and quantification of compounds, making it indispensable in drug development, quality control, and research. Additionally, advancements in liquid chromatography techniques, such as high-performance liquid chromatography (HPLC) and ultra-high-performance liquid chromatography (UHPLC), have further fueled its dominance in the market.
The Life Sciences segment is poised for significant growth in the market. This growth is primarily driven by the expanding applications of chromatography in pharmaceuticals, biotechnology, and clinical research. Chromatography plays a vital role in drug development, quality control, and biomolecule analysis, especially with the rising demand for biopharmaceuticals and personalized medicine. Additionally, the need for precise analytical tools for genomics, proteomics, and metabolomics research further propels the adoption of chromatography instruments in life sciences.
North America is expected to secure the largest market share in the market during the forecast period owing to the region's robust presence of major pharmaceutical and biotechnology companies, research institutions, and clinical laboratories, all of which heavily rely on chromatography for drug discovery, quality control, and biomolecule analysis. Moreover, stringent regulatory requirements in the healthcare and life sciences sectors drive the demand for precise analytical instrumentation. In addition, continuous emphasis on research and development, coupled with a well-established healthcare infrastructure, is fueling the growth in this region.
Asia Pacific is poised to experience substantial growth in the market. The region is witnessing a burgeoning pharmaceutical and biotechnology industry, along with increasing investments in research and development. Additionally, the expanding industrialization and urbanization in emerging economies are further fueling the need for environmental monitoring and analysis, enhancing the market's prospects. As Asia Pacific continues to evolve as a hub for scientific and industrial advancement, the adoption of chromatography instruments is expected to rise significantly.
Some of the key players in Chromatography Instruments Market include: Agilent Technologies Inc., Bio-rad, Centurion Scientific, Chromatotec, Falcon Analytical Systems & Technologies, LLC, GE Healthcare, GL Sciences, Inc., Jasco, Inc., Leco Corporation, Merck KGAA, Novasep Holding SAS, OI Corporation, Pall Corporation, Perkinelmer, Inc., Phenomenex, Inc., Restek Corporation, Scion Instrument, Shimadzu Corporation, Skyray Instrument, Sri Instrument, Thermo Fisher Scientific Inc., Trajan Scientific and Medical Pty Ltd., Valco Instrument Company Inc. and Waters Corporation.
In August 2023, Waters Corporation introduced the first in a new line of size exclusion chromatography (SEC) columns aimed at improving the analysis while lowering the cost of gene therapies, specifically adeno-associated viral (AAV) vectors. The new Waters™ XBridge™ Premier GTx BEH™ SEC columns doubles the speed of measuring the potency and safety of AAVs. Combining the columns with light scattering technologies from its Wyatt Technology portfolio deepens the level of information acquired from a single experiment and optimizes the manufacturing of these novel gene delivery vehicles.
In July 2023, Gyros Protein Technologies AB, a leading provider of peptide synthesizers and reagents, and a pioneer in automated nanoliter-scale immunoassays, today announced the launch of its PurePep® EasyClean (PEC) Auto Kit for the automated parallel purification of peptides, accelerating downstream processes for research, development, and production of simple to complex peptide drugs and therapies.
In May 2023, Waters Corporation has successfully acquired Wyatt Technology, a leading provider of light scattering and field-flow fractionation instruments, software, accessories, and services. This acquisition strengthens Waters' position in bioanalytical characterisation for emerging areas such as cell and gene therapies, which offer substantial growth opportunities. By combining Wyatt's complementary analytical technologies with Waters' global presence and expertise in simplifying complex techniques, the company is better equipped to meet the increasing demands of its customers worldwide.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.